Public Health Program for Decreasing Risk for Ebola Virus Disease Resurgence from Survivors of the 2013–2016 Outbreak, Guinea
Mory Keita, Sakoba Keita, Boubacar Diallo, Momo Camara, Samuel Mesfin, Koumpingnin Yacouba Nebie, N’Faly Magassouba, Seydou Coulibaly, Boubacar Barry, Mamadou Oury Baldé, Raymond Pallawo, Sadou Sow, Amadou Bailo Diallo, Pierre Formenty, Mamoudou Harouna Djingarey, Ibrahima Socé Fall, and Lorenzo Subissi1
Author affiliations: World Health Organization Country Office, Conakry, Guinea (M. Keita, B. Diallo, S. Mesfin, K.Y. Nebie, S. Coulibaly, B. Barry, M.O. Baldé, R. Pallawo); National Agency for Health Security, Ministry of Health, Conakry (S. Keita, M. Camara); University Gamal Abdel Nasser, Conakry (N. Magassouba, S. Sow); World Health Organization Regional Office for Africa, Brazaville, Republic of the Congo (A.B. Diallo, M.H. Djingarey, I.S. Fall); World Health Organization, Geneva, Switzerland (P. Formenty); Global Outbreak Alert and Response Network, Geneva (L. Subissi)
Figure 2. Number of specimens of body fluids from Ebola virus disease survivors tested for Ebola virus by reverse transcription PCR as part of the SA-Ceint program, Guinea, April–September 2016. All specimens tested negative except for 5 positive semen specimens from 4 survivors. Breast milk specimens were from 65 women; for all other sample types, no person had >1 samples taken.
Page created: January 17, 2020
Page updated: January 17, 2020
Page reviewed: January 17, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.